Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Neonatal hemochromatosis |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Transitory neonatal electrolyte disturbance |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal iminoglycinuria |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal cystine-lysinuria |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hypermethioninemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hypoglycemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Benign neonatal hyperaminoaciduria |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal dehydration |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hyperhistidinemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hypomagnesemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal respiratory alkalosis |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Disturbances of sodium balance of newborn |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Disturbances of potassium balance of newborn |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal pseudo-hydrocephalic progeroid syndrome |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hypocalcaemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hyperglycemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Idiopathic transient neonatal hyperinsulinaemia |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal nephrocalcinosis |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Congenital uraemia |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal overhydration |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal rickets |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal hyperbilirubinemia |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Hypoxemia in newborn (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Folinic acid-responsive seizures is a very rare neonatal epileptic encephalopathy disorder characterized clinically by myoclonic and clonic, or clonic seizures associated with apnea occurring several hours to 5 days after birth and responding to folinic acid. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Mitochondrial encephalo-cardio-myopathy due to TMEM70 mutation is characterized by early neonatal onset of hypotonia, hypertrophic cardiomyopathy and apneic spells within hours after birth accompanied by lactic acidosis, hyperammonemia and 3-methylglutaconic aciduria. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Metabolic bone disease of prematurity (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Transient neonatal multiple acyl-CoA dehydrogenase deficiency describes a very rare condition where a maternal riboflavin deficiency causes an infant to present with manifestations similar to those seen in multiple acyl-CoA dehydrogenase (MAD) deficiency such as poor suck, metabolic acidosis and hypoglycemia, but that resolves completely with oral riboflavin. In the one patient described haploinsufficiency of the human riboflavin transporter (hRFT1) was described in the mother. |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare dystrophic epidermolysis bullosa (DEB) characterized by generalized blistering at birth that usually regresses within the first 6 to 24 months of life. |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal acidosis (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal metabolic acidemia (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Syndrome of infant of mother with gestational diabetes |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal thyrotoxicosis |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal iron overload |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A type of progressive familial intrahepatic cholestasis, this disease is a severe, neonatal, hereditary disorder in bile formation that is hepatocellular in origin and not associated with extrahepatic features. Onset occurs in the neonatal period. Clinical signs of cholestasis usually appear in the first months of life with recurrent or permanent jaundice associated with hepatomegaly and severe pruritus. Patients usually develop fibrosis and end-stage liver disease before adulthood. PFIC2 is due to mutations in the ABCB11 gene (2q24) encoding the bile salt export pump (BSEP) protein resulting in impaired biliary bile acid secretion which leads to decreased bile flow and bile salt accumulation in hepatocytes with ongoing severe hepatocellular damage. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Transitory metabolic disturbance in infant of pre-diabetic mother |
Is a |
False |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by neonatal onset of severe cardiac and/or neurologic signs and symptoms mostly associated with a fatal outcome in the neonatal period or in infancy, although a milder phenotype with later onset and slowly progressive neurologic deterioration has also been reported. Clinical manifestations are variable and include respiratory insufficiency, hypotonia, cardiomyopathy, and seizures. Serum lactate is elevated in most cases. Brain imaging may show cerebellar atrophy or hypoplasia. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal jaundice with porphyria |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare genetic neurometabolic disease characterized by early neonatal refractory seizures, hypotonia, and respiratory failure. Brain imaging reveals simplified gyral pattern of the frontal lobes, white matter abnormalities, gliosis and volume loss in various brain regions, and vasogenic edema. Serum glutamine levels are significantly elevated. Death occurs within weeks after birth. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare organic aciduria characterized by neonatal onset of hypotonia, recurrent apneic episodes, lack of psychomotor development, feeding difficulties, extrapyramidal signs, and seizures. Other reported features include microcephaly, sensorineural deafness, bradycardia, and neutropenia. Laboratory studies show increased serum lactate and urinary excretion of 3-methylglutaconic acid. Brain imaging may reveal progressive cerebral atrophy. The disease is lethal in infancy. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare genetic disease characterized by the association of Fanconi syndrome and nephrocalcinosis in addition to neonatal hyperinsulinism and macrosomia. Patients display a phenotype of proximal tubulopathy characterized by generalized aminoaciduria, low molecular weight proteinuria, glycosuria, hyperphosphaturia and hypouricemia, and additional features not normally seen in Fanconi syndrome (apart from nephrocalcinosis), namely renal impairment, hypercalciuria with relative hypocalcemia, and hypermagnesemia. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Neonatal transient metabolic disturbance (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare, genetic, neonatal diabetes mellitus syndrome, that is a variant of DEND syndrome and has clinical characteristics of neonatal insulin-dependent diabetes mellitus, mild motor, speech or cognitive delay, and the absence of epilepsy. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
DEND syndrome is a very rare, generally severe form of neonatal diabetes mellitus characterized by a triad of developmental delay, epilepsy, and neonatal diabetes. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
Glucose-galactose malabsorption (disorder) |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|
A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism due to UCP2 deficiency and characterized by hypoglycemic episodes from the neonatal period, a good clinical response to diazoxide and a probable transient nature of the disease with spontaneous resolution. |
Is a |
True |
Neonatal metabolic disorder (disorder) |
Inferred relationship |
Some |
|